GLP-1 Receptor Activation May Reduce Chronic Migraine Symptoms | Retatrutide News

GLP-1 receptor activation may reduce chronic migraine symptoms through sex-specific pathways. This research could influence future GLP-1 drug developmen...
Clinical Trials · October 29, 2026